Use of p63 to differentiate high grade urothelial carcinoma from poorly differentiated prostatic adenocarcinoma

被引:0
|
作者
Baqui, AAMA [1 ]
Sun, YY [1 ]
Bhuiya, T [1 ]
机构
[1] Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
641
引用
收藏
页码:154A / 154A
页数:1
相关论文
共 50 条
  • [31] GATA3 AND P63 IMMUNOSTAINING ANALYSIS IN HIGH GRADE BLADDER CARCINOMA
    Patriarca, Carlo
    Cavallero, Alessandra
    ANTICANCER RESEARCH, 2013, 33 (05) : 2252 - 2252
  • [32] P63 and TTF-1 immunostaining: A valuable marker panel for distinguishing small cell carcinoma from poorly differentiated squamous cell carcinoma of lung
    Wu, M
    Wang, BY
    Gil, J
    Miller, L
    Gan, L
    Burstein, DE
    LABORATORY INVESTIGATION, 2002, 82 (01) : 330A - 330A
  • [33] Utility of polyclonal anti-PSA and high-molecular weight cytokeratin immunohistochemistry in the differentiation of poorly differentiated prostatic carcinoma from urothelial carcinoma
    Varma, M
    Jasani, B
    Mathews, PN
    Datta, SN
    Amin, AB
    LABORATORY INVESTIGATION, 2006, 86 : 167A - 167A
  • [34] p63 and TTF-1 immunostaining: A valuable marker panel for distinguishing small cell carcinoma from poorly differentiated squamous cell carcinoma of lung
    Wu, M
    Wang, BY
    Gil, J
    Miller, L
    Gan, L
    Burstein, DE
    MODERN PATHOLOGY, 2002, 15 (01) : 330A - 330A
  • [35] Utility of polyclonal anti-PSA and high-molecular weight cytokeratin immunohistochemistry in the differentiation of poorly differentiated prostatic carcinoma from urothelial carcinoma
    Varma, M
    Jasani, B
    Mathews, PN
    Datta, SN
    Amin, MB
    MODERN PATHOLOGY, 2006, 19 : 167A - 167A
  • [36] High grade prostatic adenocarcinoma with a partly intraductal growth pattern producing a mimic of urothelial carcinoma in situ
    Shaw, Emily Clare
    Oxley, Jon D.
    Varma, Muralidharan
    Theake, Jeffrey
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (08) : 729 - 731
  • [37] Immunophenotype of intermediate and high grade prostatic and urothelial carcinoma.
    Hutchinson, B
    Reuter, VE
    Gaudin, PB
    LABORATORY INVESTIGATION, 1999, 79 (01) : 98A - 98A
  • [38] Prostatic Carcinoma With Aberrant Expression of p63: A Case Report and Review of the Literature
    Paulk, Adina
    McCool, Isaac
    Sesterhenn, Isabell
    Burke, Allen
    AJSP-REVIEWS AND REPORTS, 2020, 25 (03): : 129 - 132
  • [39] High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung
    Choy, Bonnie
    Findeis-Hosey, Jennifer J.
    Li, Faqian
    McMahon, Loralee A.
    Yang, Qi
    Xu, Haodong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (11): : 2542 - 2547
  • [40] p63 and TTF-1 immunostaining - A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung
    Wu, MX
    Wang, B
    Gil, J
    Sabo, E
    Miller, L
    Gan, L
    Burstein, DE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (05) : 696 - 702